"To me it sounds like a phase 3 at this point would be irresponsible. Either it works or it doesn’t."
Godel's incompleteness theorem says: "Something that is true cannot always be proven". Unfortunately @Vivo, this can be proven and will have to be proven and there is a process. We are following the process and we really better not walk ahead of ourselves. As Tribel said, all patient in AIPAC trial would die otherwise - So, if we get some positive results in a few months time we should be EXTREMELY happy, howeverway it goes from there. FDA, EMA, Tribel (as CMO and CSO) are all very well versed on cancer and clinical trials. If this goes to Phase 3, it should not be seen AT ALL as a hinderance. It is a badge of honour! Phase II is THE bottle neck of trials and if we move past it into phase 3, I would be so very positive.
"Just venting my frustration at the glacial speed of progress in this industry of which Immutep is just another example". I think you may have meant; Immutep in the race, however the nature of the beast pace-wise. Mate, had things been at a faster pace in this game we would not even have cancer as a word in the dictionary anymore!!!
- Forums
- ASX - By Stock
- Media
"To me it sounds like a phase 3 at this point would be...
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $465.4M |
Open | High | Low | Value | Volume |
31.5¢ | 32.5¢ | 31.0¢ | $1.599M | 5.009M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 65758 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 6777 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 65758 | 0.315 |
12 | 444095 | 0.310 |
8 | 88834 | 0.305 |
11 | 76665 | 0.300 |
6 | 80083 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 6777 | 1 |
0.325 | 282659 | 7 |
0.330 | 163630 | 7 |
0.335 | 146632 | 3 |
0.340 | 80000 | 2 |
Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |